Aktien Sensor

Humana Inc.’s stock declined 12% due to concerns over tightened Medicare bonus payment criteria, but the company’s CenterWell division secured a strategic acquisition to potentially offset the impact and drive long-term growth.

STERIS PLC, a leading provider of healthcare equipment and supplies, is well-positioned for growth in the expanding market for disposable medical devices, driven by trends in infection prevention, chronic disease management, and point-of-care testin…

Regeneron Pharmaceuticals Inc has announced significant advancements in its oncology portfolio, including positive five-year follow-up data for its Libtayo treatment in advanced non-small cell lung cancer, and a definitive settlement with Sandoz to …

Boston Scientific Corporation has demonstrated robust growth over the past year, driven by a strong product pipeline, global expansion, and operational efficiency, and has further solidified its position with a strategic acquisition of Elutia’s bioe…

AbbVie Inc. sees its stock rise 3% after securing a significant licensing deal with Glenmark Pharmaceuticals, while also expanding its portfolio in psychedelic medicine through various collaborations and investments.

GE Healthcare has announced a dual-strategy approach, partnering with CardioNavix to bring advanced cardiac imaging agent Flyrcado to the US and launching the Revolution Vibe CT Imaging System, which promises to raise the bar for image quality and w…

Genmab A/S, a Danish biotech firm, is experiencing a modest surge in its share price, but underlying volatility and rising short interest suggest that investors remain skeptical about the company’s long-term viability and potential for growth.

Daiichi Sankyo Co., Ltd. is accelerating its expansion and research and development momentum through strategic investments in China, clinical trials, and partnerships, positioning the company for sustained growth and market leadership in the pharmac…

The share price of Shanghai Fosun Pharmaceutical Group Co Ltd surged 3.2% to 42.30 CNY, driven by a combination of positive sector sentiment, strong company fundamentals, and supportive analyst commentary.

Edwards Lifesciences Corp. has demonstrated a resilient performance in the cardiovascular innovation space, driven by its leadership in the TAVR market, but faces challenges in maintaining its competitive edge amidst market volatility and external e…